Emerging Therapeutic Targets and Drug Delivery Approaches in IBD
Academic Press Inc (Verlag)
978-0-443-31358-5 (ISBN)
- Noch nicht erschienen (ca. Dezember 2024)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Additional sections cover BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases, Scripps - S1P, The potential of targeting TREM-1 in Inflammatory Bowel Disease, and Microbiome therapies.
1. Fibrosis in IBD – AXL as a Promising Therapeutic Target
Calen Steiner and P Higgins
2. Developing a pathway to test anti-fibrotic drugs in Crohn’s disease
Florian Rieder
3. Emerging therapeutics for the management of intestinal fibrosis and strictures
Laura Ensign and Florin M. Selaru
4. GCPII for IBD
Diane E. Peters
5. Fistulas/stem cell products for IBD/Crohn’s
Hai-Quan Mao
6. The landscape of new therapeutic opportunities for IBD
Andres Hurtado-Lorenzo and Jennifer L. Swantek
7. TL1A : A Model For The Use Of Precision Medicine For The Treatment of Crohn’s Disease and Ulcerative Colitis
Stephan Targan
8. Dectin-1 as a therapeutic target for IBD
Xiaolei Zhu
9. BRD4 as an Emerging Epigenetic Therapeutic Target for Inflammatory Bowel Diseases
Jia Zhou
10. Scripps - S1P
Hugh Rosen
11. The potential of targeting TREM-1 in Inflammatory Bowel Disease
Marc Derive
12. Microbiome therapies
Christopher Burton Ford
| Erscheint lt. Verlag | 1.12.2024 |
|---|---|
| Reihe/Serie | Advances in Pharmacology |
| Verlagsort | San Diego |
| Sprache | englisch |
| Maße | 152 x 229 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| ISBN-10 | 0-443-31358-X / 044331358X |
| ISBN-13 | 978-0-443-31358-5 / 9780443313585 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
